Woburn, MA – According to filings with the U.S. Securities and Exchange Commission, NanoMosaic is raising $40,750,000.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Joe Wilkinson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NanoMosaic
NanoMosaic Inc. is a manufacturer of nanoneedle proteomic beta system intended to assist in proteomics. The companys platform leverages the power of nanoneedles for protein detection and quantification, enabling the medical and healthcare industry to accelerate biomarker discovery and validation. Next generation protein interrogation powered by nanoneedles, enabling early disease detection, prognostic monitoring and biomarker discovery on a single chip. Fully-customizable panels to meet unique customer needs, as well as standard format panels. High-multiplex, proteome-wide association study to discover protein targets. High-sensitivity, wide-dynamic range, multiplexed protein quantitation.

To learn more about NanoMosaic, visit http://www.nanomosaicllc.com/

Contact:
Joe Wilkinson, Chief Operating Officer
617-925-7771
https://www.linkedin.com/in/joe-wilkinson-a5896519/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved